Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited have stated that they take no responsibility for the contents of the announcement referenced here, make no representation regarding its accuracy or completeness, and expressly disclaim any liability for any loss arising from or in reliance upon any part of its contents.

Zhong Ji Longevity Science Group Limited (the Company, Stock Code: 767) has announced a further delay in the dispatch of a circular pertaining to a major and connected transaction regarding the acquisition of 25% of the issued share capital of Asian Integrated Cell Laboratory Limited. The acquisition involves the issuance of convertible notes under a specific mandate.

According to the Company’s prior disclosure, the circular—containing details on the target company, the Sale and Purchase Agreement, the Independent Board Committee’s recommendation, an independent financial adviser’s opinion, financial information on the target company, and notice of the special general meeting—was originally planned to be sent to shareholders on or before 9 February 2026. The Company now states that additional time is required to finalize certain information, and the expected date of dispatch is postponed to on or before 6 March 2026.